Literature DB >> 8378893

Vitamin K-dependent carboxylase activity, prothrombin mRNA, and prothrombin production in two cultured rat hepatoma cell lines.

D V Shah1, P Zhang, J A Engelke, A U Bach, J W Suttie.   

Abstract

The presence of under-gamma-carboxylated forms of plasma prothrombin is a marker for human primary hepatocellular carcinoma. A rat hepatoma cell line (7777) which was previously shown to secrete undercarboxylated prothrombin when grown as a solid tumor has now been grown in monolayer culture. This cell line has a decreased activity of the microsomal vitamin K-dependent carboxylase when compared to a control (H4IIEC3) hepatoma line, does not increase intracellular prothrombin concentrations in response to vitamin K depletion, and secretes undercarboxylated prothrombin even when grown in vitamin K supplemented media. Prothrombin gene expression in the 7777 cell line, as measured by prothrombin mRNA levels, was not altered in the 7777 cell line. This cell line appears to be a model for assessing the cellular alterations responsible for undercarboxylated prothrombin excretion by human hepatocellular tumors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8378893     DOI: 10.1016/0049-3848(93)90078-3

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  3 in total

Review 1.  Clinical application of protein induced by vitamin K antagonist-II as a biomarker in hepatocellular carcinoma.

Authors:  Hao Xing; Cunling Yan; Liming Cheng; Nianyue Wang; Shuyang Dai; Jianyong Yuan; Wenfeng Lu; Zhouchong Wang; Jun Han; Yijie Zheng; Tian Yang
Journal:  Tumour Biol       Date:  2016-10-13

2.  Effect of sorafenib on des-γ-carboxyprothrombin secretion by a human hepatocellular carcinoma cell line.

Authors:  Sachiko Ogasawara; Masamichi Nakayama; Jun Akiba; Hironori Kusano; Hirohisa Yano
Journal:  Oncol Lett       Date:  2017-06-21       Impact factor: 2.967

3.  Vitamin K contents in liver tissue of hepatocellular carcinoma patients.

Authors:  T Miyakawa; Y Kajiwara; A Shirahata; K Okamoto; H Itoh; K Ohsato
Journal:  Jpn J Cancer Res       Date:  2000-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.